2021 guidance re- re confirmedTD summary excellent :
«
2021 Guidance Reiterated: ALA continues to expect 2021 normalized EBITDA and normalized EPS of $1.475-$1.525Bn and $1.65-$1.80, respectively.» and no bad surprise.
Nothing to add and an uppward share price action to be ''modest''in the coming year.
Bottom line :Good investment to keep in a porfolio say up to 20% as a core value.
Cheers.